Senate Rejects Inquiry Into COVID-19 Response
- Australian Senate rejects a call for establishing a Commission of Inquiry into the government's COVID-19 response.
- Senator Ralph Babet's proposal for an inquiry into pandemic response fails to get support.
- The Senate decision signifies the rejection of a deeper investigation into Australia's handling of the pandemic.
In a recent Senate vote, Australian senators rejected a motion proposed by United Australia Party Senator Ralph Babet to establish a Commission of Inquiry into the government's COVID-19 pandemic response. Babet criticized both Liberal and Labor senators for their opposition, arguing that accountability for government actions during the pandemic is essential. The motion failed with 32 votes against and 28 in favor, despite ongoing inquiries into the Commonwealth government's pandemic response and excess mortality. The debate surrounding the inquiry resurfaced in late 2023, as the Senate referred the matter to the Legal and Constitutional Affairs References Committee, predominantly composed of Liberal Party members. This committee recommended the establishment of a royal commission to thoroughly examine the Australian response to the pandemic and its impacts on the community. However, they noted that such inquiries often take years to yield results, with some lasting up to five years. Opposition leader Peter Dutton criticized the inquiry announced by Prime Minister Anthony Albanese, labeling it a "protection racket" for Labor premiers due to its limited scope, which excludes state responses. In response, Senator Ayres emphasized the need for responsible political leadership, asserting that prioritizing the Australian people's interests is paramount, even at the cost of party positions. The current independent inquiry into the Commonwealth's pandemic response has faced significant criticism for its perceived inadequacy, with various organizations, including the Australian Industry Group and the Royal Australian College of General Practitioners, expressing concerns over its effectiveness.